Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
27.5M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
11.4M
-
Shares change
-
+361K
-
Total reported value, excl. options
-
$92.1M
-
Value change
-
+$2.92M
-
Put/Call ratio
-
1.36
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$8.10
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q3 2022
41 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q3 2022.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4M shares
of 27.5M outstanding shares and own 41.41% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Sonic Fund II, L.P. (2.41M shares), Avoro Capital Advisors LLC (1.2M shares), Solas Capital Management, LLC (1.13M shares), DG Capital Management, LLC (1.01M shares), 683 Capital Management, LLC (385K shares), MILLENNIUM MANAGEMENT LLC (249K shares), HARBERT FUND ADVISORS, INC. (190K shares), EAM Investors, LLC (177K shares), and Tamarack Advisers, LP (175K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.